搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
9 小时
A Popular Asthma Drug May Be Causing Brain Damage
New data collected by the FDA has found that montelukast can bind to brain cells, which may explain the risk of mental health ...
News Medical on MSN
2 天
New discovery reveals dual binding in bitter taste receptors
"Tasting Upside-Down - An Unusual Sensing Mechanism was Found in Human Bitter Sensing" A new study revealed that some bitter ...
1 天
on MSN
Drug, now in testing, has promise for epileptic seizures
UC San Diego is among more than 100 locations nationwide participating in new clinical trials for a drug that shows promise ...
16 小时
on MSN
Amgen Obesity Drug More Effective Than Competitors
A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.
4 天
on MSN
Popular asthma drug Singulair could be linked to mental health side effects, suicides: FDA
Singulair, a popular asthma medication, could be linked to severe side effects, including suicide, a study from the FDA found ...
3 天
on MSN
As many as 1 in 5 people won't lose weight with GLP-1 drugs, experts say
About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to ...
4 天
on MSN
Popular asthma drug may be linked to serious mental health problems
"It's definitely doing something that's concerning," one scientist said about reported side effects of the drug.
Medical Xpress on MSN
9 天
How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms ...
University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into ...
EurekAlert!
8 天
New study unveils key strategies against drug-resistant prostate cancer
An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...
FierceBiotech
6 天
AstraZeneca cans phase 2 opioid use disorder drug over interaction with common antifungal med
AstraZeneca has ended work on an opioid use disorder (OUD) drug after the orexin 1 receptor antagonist demonstrated a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈